ProfileGDS4718 / 212967_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 93% 91% 99% 89% 92% 99% 99% 93% 92% 93% 92% 96% 96% 98% 98% 96% 93% 98% 99% 99% 91% 93% 92% 93% 95% 98% 92% 99% 92% 99% 96% 99% 89% 87% 98% 99% 98% 96% 95% 99% 94% 98% 99% 98% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.8704893
GSM549102patient 115, normal, homogenized [OPG study]9.4120491
GSM549104patient 119, normal, homogenized [OPG study]12.087199
GSM549108patient 138, normal, homogenized [OPG study]9.0234989
GSM549119patient 077, normal, homogenized [OPG study]9.532492
GSM549133patient 032, cancer, homogenized [OPG study]11.879899
GSM549139patient 042, cancer, homogenized [OPG study]11.794299
GSM549099patient 107, normal, homogenized [OPG study]9.6799893
GSM549109patient 139, normal, homogenized [OPG study]9.6098492
GSM549110patient 046, normal, homogenized [OPG study]9.9099193
GSM549114patient 063, normal, homogenized [OPG study]9.822892
GSM549122patient 082, normal, homogenized [OPG study]10.681396
GSM549134patient 033, cancer, homogenized [OPG study]10.593296
GSM549136patient 036, cancer, homogenized [OPG study]11.751798
GSM549140patient 044, cancer, homogenized [OPG study]11.661998
GSM549111patient 047, normal, homogenized [OPG study]10.823496
GSM549113patient 057, normal, homogenized [OPG study]10.059493
GSM549132patient 031, cancer, homogenized [OPG study]11.192898
GSM549137patient 038, cancer, homogenized [OPG study]12.188599
GSM549142patient 047, cancer, homogenized [OPG study]11.728399
GSM549100patient 110, normal, homogenized [OPG study]9.4517591
GSM549107patient 135, normal, homogenized [OPG study]9.9470293
GSM549115patient 068, normal, homogenized [OPG study]9.8607292
GSM549116patient 072, normal, homogenized [OPG study]9.8820493
GSM549120patient 078, normal, homogenized [OPG study]10.178795
GSM549131patient 030, cancer, homogenized [OPG study]11.615598
GSM549118patient 074, normal, homogenized [OPG study]9.625692
GSM549129patient 027, cancer, homogenized [OPG study]11.606599
GSM549123patient 088, normal, homogenized [OPG study]9.7259492
GSM549124patient 006, cancer, homogenized [OPG study]11.677199
GSM549126patient 015, cancer, homogenized [OPG study]10.473196
GSM549128patient 025, cancer, homogenized [OPG study]11.788799
GSM549103patient 117, normal, homogenized [OPG study]8.9635989
GSM549117patient 073, normal, homogenized [OPG study]8.8880687
GSM549138patient 041, cancer, homogenized [OPG study]11.463898
GSM549141patient 045, cancer, homogenized [OPG study]11.779799
GSM549130patient 028, cancer, homogenized [OPG study]11.369198
GSM549101patient 111, normal, homogenized [OPG study]10.357496
GSM549105patient 128, normal, homogenized [OPG study]10.119495
GSM549106patient 134, normal, homogenized [OPG study]12.231699
GSM549112patient 048, normal, homogenized [OPG study]10.047994
GSM549125patient 011, cancer, homogenized [OPG study]11.233898
GSM549127patient 024, cancer, homogenized [OPG study]11.744999
GSM549135patient 035, cancer, homogenized [OPG study]11.769298